Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PharmacofMRI of Pregabalin
NCT00706836Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pregabalin in anxiety disorders (3 arms), sponsored by University of California, San Diego. Primary endpoint: Effect of Pregabalin (Two Doses) Versus Placebo on Amygdala and Insula Activity at Week 3. Started Jun 2008; status: completed.
02
Drugs
pregabalin
03
Conditions
anxiety disorders
Beyond the preview
Go deeper on NCT00706836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706836.